Skip to Content

Startups, Partnerships Fuel New Technology at U

otc report

It sounds like a puzzle pulled from the pages of a medical textbook: Imagine you wanted to treat cancer by blocking the blood flow to a tumor, but needed the artery to open itself back up later.

Dr. Jafar Golzarian, director of interventional radiology at the University of Minnesota, solved the puzzle and brought its solution to life. His natural polymer bead, which breaks down after a period of time, fit the bill and was so promising it gave root to EmboMedics, a new medical technology company.

Golzarian’s invention is one of the many research projects the U has spun off as a startup over the years to help new technology reach the market. The U launched a record 14 startups during fiscal 2013, according to a recent Office for Technology Commercialization report on the U’s growing tech transfer efforts.

While new companies are bringing U technology to market, partnerships between departments are thriving back on campus. College of Pharmacy Dean Dr. Marilyn Speedie and her team are partnering with OTC to patent and commercialize their research, which includes new therapeutics for a wide range of diseases.

Across the board, OTC Executive Director Jay Schrankler said the U is bringing in more invention disclosures and filing more patents than ever before.

“Our goal is to maintain this innovative spirit, stay at the forefront of technology management, and to continue developing new ideas and programs in 2014,” Schrankler said.

Originally published on Business @ the U of M.

Kevin Coss

Kevin Coss

Kevin is a writer with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Dr. Friedemann-Sanchez and Dr. Grieve sitting at a table together.

In 2018, two University of Minnesota researchers traveled to a United Nations council meeting to advocate for changes to address an epidemic of violence against women in Colombia.

Read More
Senior man speaks with a health care provider while looking at a digital display

Researchers aim to help train pharmacists and educate patients with the goal of improving medication outcomes for groups with higher rates of kidney failure.

Read More
Sironix banner in a laboratory space

Sironix Renewables uses a patented method to make nontoxic, sustainably-sourced surfactants that replace their counterparts made from petroleum.

Read More
Border crossing checkpoint from Mexico to US

As an expert witness on federal immigration court cases, Patrick McNamara provides insight into violence directly and indirectly related to drug cartels.

Read More